Emergency Contraceptive Pills Market Size, Share, Trends , Demand, Growth and Analysis by 2028

 IMARC Group, a leading market research company, has recently releases report titled “Emergency Contraceptive Pills Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global emergency contraceptive pills market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How big is the emergency contraceptive pills market?

The global emergency contraceptive pills market size reached US$ 561.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 736.7 Million by 2028, exhibiting a growth rate (CAGR) of 4.74% during 2023-2028.

What are Emergency Contraceptive Pills?

Emergency contraceptive pills (ECPs), commonly referred to as "morning-after pills," are a form of contraception designed to prevent unintended pregnancies after unprotected sexual intercourse or contraceptive failure. These pills typically contain a synthetic version of the hormone progestin, or a combination of progestin and estrogen, which work by inhibiting ovulation, altering the cervical mucus to hinder sperm mobility, and possibly affecting the uterine lining to prevent implantation of a fertilized egg. ECPs are not meant for regular contraceptive use and are most effective when taken within 72 hours of unprotected intercourse, though some formulations have extended efficacy windows. They offer a valuable option for individuals seeking timely and discreet prevention of unintended pregnancies.

Request for a sample report or buy full report: https://www.imarcgroup.com/emergency-contraceptive-pills-market/requestsample

What are the growth prospects and trends in the emergency contraceptive pills industry?

The rising awareness about sexual and reproductive health, especially among the younger population, is leading to a greater understanding of available contraceptive options, including ECPs which represents one of the key factors driving the growth of the market across the globe. In line with this, comprehensive sex education and access to reliable information are empowering individuals to make informed decisions about their reproductive choices which is boosting the growth of the market. The market is also driven by modern lifestyles often involving dynamic social interactions and changing relationship dynamics. This is contributing to an increased need for accessible and effective methods of contraception in cases of contraceptive failure or unprotected intercourse which is further fueling the growth of the market. In addition to this, the increasing focus on women's health, the rising unintended pregnancies, and rapid urbanization and digital connectivity, are some of the other factors creating a positive outlook for the market across the globe.

Who are the key players operating in the industry?

The report covers the major market players including:

• Afaxys Pharma LLC
• Foundation Consumer Healthcare LLC
• Gedeon Richter Plc
• HLL Lifecare Limited
• Perrigo Company plc
• Piramal Enterprises Ltd.
• Syzygy Healthcare Solutions LLC

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

• Combination Pills
• Progesterone Pills
• Others

Breakup by Distribution Channel:

• Retail Stores
• Online Stores
• Others

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=7773&flag=C

Key Highlights of the Report:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: https://twitter.com/ImarcServices

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/